A150 ASSOCIATION BETWEEN SERUM USTEKINUMAB CONCENTRATIONS AND ENDOSCOPIC DISEASE ACTIVITY IN CROHN’S DISEASE

BACKGROUND: Therapeutic drug monitoring, the measurement of serum biologic concentrations and immunogenicity, has become an important method in guiding the management of biologic therapy in patients with Crohn’s disease (CD). Ustekinumab, an inhibitor of the p40 subunit of interleukins 12 and 23, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanofsky, R, Abduallah, Y, Golovics, P, Lakatos, P L, Bitton, A, Wild, G, Afif, W, Bessissow, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster of Distinction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859224/
http://dx.doi.org/10.1093/jcag/gwab049.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859224/
http://dx.doi.org/10.1093/jcag/gwab049.149

Ejemplares similares